All Stories

  1. In early rheumatoid arthritis, comorbidities do not explain the increased risk of failure to reach remission in patients with obesity

    Article • RMD Open, April 2025, BMJ

    Benedicte Delcoigne

  2. Incidence, stage and outcome of malignant melanoma, keratinocyte and other cancers in individuals with vitiligo or alopecia: intraindividual or familial risks?

    Article • British Journal of Dermatology, February 2025, Oxford University Press (OUP)

    Benedicte Delcoigne

  3. Are JAKis more effective among elderly patients with RA, smokers and those with higher cardiovascular risk? A comparative effectiveness study of b/tsDMARDs in Sweden

    Article • RMD Open, December 2023, BMJ

    Benedicte Delcoigne

  4. Comorbidities and chance of remission in patients with early rheumatoid arthritis receiving methotrexate as first-line therapy: a Swedish observational nationwide study

    Article • RMD Open, December 2023, BMJ

    Benedicte Delcoigne

  5. Disease‐modifying antirheumatic drugs and risk of thyroxine‐treated autoimmune thyroid disease in patients with rheumatoid arthritis

    Article • Journal of Internal Medicine, November 2023, Wiley

    Benedicte Delcoigne

  6. Comparative cardiovascular safety with janus kinase inhibitors and biological disease-modifying antirheumatic drugs as used in clinical practice: an observational cohort study from Sweden in patients with rheumatoid arthritis

    Article • RMD Open, November 2023, BMJ

    Benedicte Delcoigne

  7. How does current disease activity in rheumatoid arthritis affect the short-term risk of acute coronary syndrome? A clinical register based study from Sweden and Norway

    Article • European Journal of Internal Medicine, September 2023, Elsevier

    Benedicte Delcoigne

  8. OP0133 DO JAKIS WORK THE BEST AMONG THOSE RA PATIENTS WHERE THEIR SAFETY CONCERNS ARE THE HIGHEST?

    Article • May 2023, BMJ

    Benedicte Delcoigne

  9. Risk of Psychiatric Disorders in Juvenile Idiopathic Arthritis: Population‐ and Sibling‐Controlled Cohort and Cross‐Sectional Analyses

    Article • ACR Open Rheumatology, May 2023, Wiley

    Benedicte Delcoigne

  10. A Healthy Lifestyle in Men at Increased Genetic Risk for Prostate Cancer

    Article • European Urology, April 2023, Elsevier

    Benedicte Delcoigne

  11. Glucocorticoid exposure and the risk of serious infections in rheumatoid arthritis: a marginal structural model application

    Article • Rheumatology, February 2023, Oxford University Press (OUP)

    Benedicte Delcoigne

  12. Safety of biological and targeted synthetic disease-modifying antirheumatic drugs for rheumatoid arthritis as used in clinical practice: results from the ARTIS programme

    Article • Annals of the Rheumatic Diseases, February 2023, BMJ

    Benedicte Delcoigne

  13. Exposure to specific tumour necrosis factor inhibitors and risk of demyelinating and inflammatory neuropathy in cohorts of patients with inflammatory arthritis: a collaborative observational study across five Nordic rheumatology registers

    Article • RMD Open, February 2023, BMJ

    Benedicte Delcoigne, Elizabeth Arkema

  14. Federated analyses of multiple data sources in drug safety studies

    Article • Pharmacoepidemiology and Drug Safety, December 2022, Wiley

    Benedicte Delcoigne

  15. Comorbidities and treatment patterns in early rheumatoid arthritis: a nationwide Swedish study

    Article • RMD Open, December 2022, BMJ

    Benedicte Delcoigne

  16. Haematological malignancies in patients with psoriatic arthritis overall and treated with TNF inhibitors: a Nordic cohort study

    Article • RMD Open, December 2022, BMJ

    Benedicte Delcoigne, Thorvardur Love

  17. Venous thromboembolism with JAK inhibitors and other immune-modulatory drugs: a Swedish comparative safety study among patients with rheumatoid arthritis

    Article • Annals of the Rheumatic Diseases, September 2022, BMJ

    Benedicte Delcoigne

  18. Does persistence to methotrexate treatment in early rheumatoid arthritis have a familial component?

    Article • August 2022, Springer Science + Business Media

    Benedicte Delcoigne

  19. Correction to: Do patient-reported measures of disease activity in rheumatoid arthritis vary between countries? Results from a Nordic collaboration

    Article • Rheumatology, March 2022, Oxford University Press (OUP)

    Benedicte Delcoigne

  20. The impact of a csDMARD in combination with a TNF inhibitor on drug retention and clinical remission in axial spondyloarthritis

    Article • Rheumatology, March 2022, Oxford University Press (OUP)

    Benedicte Delcoigne

  21. Short-term, intermediate-term and long-term risks of acute coronary syndrome in cohorts of patients with RA starting biologic DMARDs: results from four Nordic countries

    Article • Annals of the Rheumatic Diseases, March 2022, BMJ

    Benedicte Delcoigne

  22. Do patient-reported measures of disease activity in rheumatoid arthritis vary between countries? Results from a Nordic collaboration

    Article • Rheumatology, February 2022, Oxford University Press (OUP)

    Benedicte Delcoigne

  23. Comparison of treatment retention of originator vs biosimilar products in clinical rheumatology practice in Sweden

    Article • Rheumatology, December 2021, Oxford University Press (OUP)

    Benedicte Delcoigne

  24. Effects of the COVID-19 pandemic on patients with inflammatory joint diseases in Sweden: from infection severity to impact on care provision

    Article • RMD Open, December 2021, BMJ

    Benedicte Delcoigne

  25. Influenza outcomes in patients with inflammatory joint diseases and DMARDs: how do they compare to those of COVID-19?

    Article • Annals of the Rheumatic Diseases, November 2021, BMJ

    Benedicte Delcoigne

  26. Effectiveness and treatment retention of TNF inhibitors when used as monotherapy versus comedication with csDMARDs in 15 332 patients with psoriatic arthritis. Data from the EuroSpA collaboration

    Article • Annals of the Rheumatic Diseases, June 2021, BMJ

    Benedicte Delcoigne, Thorvardur Love

  27. Impact of the COVID-19 pandemic on morbidity and mortality in patients with inflammatory joint diseases and in the general population: a nationwide Swedish cohort study

    Article • Annals of the Rheumatic Diseases, February 2021, BMJ

    Benedicte Delcoigne

  28. Risk of solid cancers overall and by subtypes in patients with psoriatic arthritis treated with TNF inhibitors – a Nordic cohort study

    Article • Rheumatology, January 2021, Oxford University Press (OUP)

    Benedicte Delcoigne, Thorvardur Love

  29. Comorbidities at diagnosis of rheumatoid arthritis: a population-based case-control study

    Article • Rheumatology, December 2020, Oxford University Press (OUP)

    Benedicte Delcoigne

  30. How do we use biologics in rheumatoid arthritis patients with a history of malignancy? An assessment of treatment patterns using Scandinavian registers

    Article • RMD Open, September 2020, BMJ

    Benedicte Delcoigne

  31. Does autoimmune thyroid disease affects rheumatoid arthritis disease activity or response to methotrexate?

    Article • RMD Open, July 2020, BMJ

    Benedicte Delcoigne

  32. Gastrointestinal perforations in patients with rheumatoid arthritis treated with biological disease-modifying antirheumatic drugs in Sweden: a nationwide cohort study

    Article • RMD Open, July 2020, BMJ

    Benedicte Delcoigne

  33. Response to: ‘Neuroinflammatory events after anti-TNFα therapy’ by Kaltsonoudiset al

    Article • Annals of the Rheumatic Diseases, May 2020, BMJ

    Benedicte Delcoigne, Elizabeth Arkema

  34. Siblings of patients with rheumatoid arthritis have an increased mortality rate: a Swedish cohort study

    Article • RMD Open, May 2020, BMJ

    Benedicte Delcoigne

  35. Risk of neuroinflammatory events in arthritis patients treated with tumour necrosis factor alpha inhibitors: a collaborative population-based cohort study from Denmark and Sweden

    Article • Annals of the Rheumatic Diseases, March 2020, BMJ

    Benedicte Delcoigne, Elizabeth Arkema

  36. Blood neurofilament light levels segregate treatment effects in multiple sclerosis

    Article • Neurology, February 2020, Wolters Kluwer Health

    Benedicte Delcoigne, Professor Fredrik Piehl

  37. Juvenile idiopathic arthritis and risk of cancer before and after the introduction of biological therapies

    Article • RMD Open, November 2019, BMJ

    Benedicte Delcoigne

  38. SAT0650 THE INFLUENCE OF PATIENT DEMOGRAPHICS ON DISEASE ACTIVITY MEASUREMENTS IN RHEUMATOID ARTHRITIS

    Article • May 2019, BMJ

    Benedicte Delcoigne

  39. OP0001 Risk of malignancy in children with juvenile idiopathic arthritis: a register-based cohort study

    Article • June 2018, BMJ

    Benedicte Delcoigne

  40. Valid and efficient subgroup analyses using nested case-control data

    Article • International Journal of Epidemiology, January 2018, Oxford University Press (OUP)

    Benedicte Delcoigne

  41. Breaking the matching in nested case–control data offered several advantages for risk estimation

    Article • Journal of Clinical Epidemiology, February 2017, Elsevier

    Benedicte Delcoigne

  42. Comparisons of risk prediction methods using nested case-control data

    Article • Statistics in Medicine, October 2016, Wiley

    Dr Agus Salim, Benedicte Delcoigne

  43. Feasibility of reusing time-matched controls in an overlapping cohort

    Article • Statistical Methods in Medical Research, September 2016, SAGE Publications

    Benedicte Delcoigne

  44. European Collaborative Project on Affective Disorders

    Article • Psychiatric Genetics, January 1998, Wolters Kluwer Health

    Benedicte Delcoigne